COVID-19 trials registries data warehouse

 Return to trial list

Trial - EUCTR2021-000930-32-BE


Column Value
Trial registration number EUCTR2021-000930-32-BE
Full text link
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

First author
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

clinical trial center - CTC

Contact
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

ctc@azsintjan.be

Registration date
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

2021-03-04

Recruitment status
Last imported at : Oct. 15, 2022, 12:30 a.m.
Source : EU Clinical Trials Register

Completed

Study design
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

nonRCT

Allocation
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

Non-randomized

Design
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

Single group assignment

Masking
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

Open label

Center
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

multi-center

Study aim
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

Prevention

Inclusion criteria
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

1. Consecutive series of hemodialysis patients receiving Covid-19 RNA vaccine. A target of at least 100 patients is envisioned. Minimum age for inclusion is 18 years. 2. at least thirty healthy volunteers receiving Covid-19 RNA vaccine. Minimum age for inclusion is 18 years. Individuals with immune disorders cannot participate. 3. at least thirty patients older than 50 years with at least 1 comorbidity (such as heart failure, diabetes, COPD, liver cirrhosis,....), but no chronic renal insufficiency. Minimum age for inclusion is 18 years. Only patients who receive vaccine on a voluntary basis will be included.

Exclusion criteria
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

- patients younger than 18 years old - patients who do not voluntarily ask for a COVID-vaccination - patients not eligible according to abovementioned inclusion criteria

Number of arms
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

1

Funding
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

AZ Sint-Jan Brugge-Oostende AV

Inclusion age min
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

18

Inclusion age max
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

100

Countries
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

Belgium

Type of patients
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

High risk patients

Severity scale
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

N/A

Total sample size
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

580

primary outcome
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

1. Measurement of anti-S and anti-N antibodies. SARS-CoV-2 IgG against the S and N protein will be quantitatively measured by chemiluminescent microparticle immunoassay (Architect-I System by Abbott, Sligo, Ireland). 2. Measurement of interferon gamma production. Interferon production by SARS-CoV specific T cells will be measured using the QuantiFERON Sars-CoV-2 kit (Qiagen). 3. Baseline immune status (only in hemodialysis patients). Before vaccination the following parameters are determined: number of lymphocytes, number of CD4 positive lymphocytes, number of CD8 positive lymphocytes, number of CD19 positive lymphocytes, B and T cell memory subsets, protein electrophoresis, C3, C4, total IgG, IgA and IgM.

Notes
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

Declared number of arm (1.0) differs from found arms (2.0)

Phase
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register

Phase 4

Arms
Last imported at : Oct. 15, 2022, 12:30 a.m.
Source : EU Clinical Trials Register

[{"arm_notes": "", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 824, "treatment_name": "Mrna-1273", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}]